Recruiting PHASE4 INTERVENTIONAL 2-arm
NCT06812832
Simethicone as Part of ERAS in Bariatric Surgery Patients
Simethicone as Part of an Enhanced Recovery After Surgery (ERAS) Protocol
Sponsor: Madigan Army Medical Center
Conditions
Bariatric Surgery Post-operative Pain Simethicone
Interventions
Placebo Simethicone 80 MG
Updated 2 times since 2025 Last updated: Jun 11, 2025 Started: Apr 8, 2025 Primary completion: Mar 31, 2028 Completion: Mar 31, 2029
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This PHASE4 trial investigates Bariatric Surgery and Post-operative Pain and is currently actively recruiting participants. Madigan Army Medical Center leads this study, which shows 2 recorded versions since 2025 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
2 versions recorded-
Jul 2025 — Present [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Mar 2025 — Jul 2025 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Madigan Army Medical Center
Data source: Madigan Army Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .